%0 Journal Article
%T 癌&#8211;睾丸抗原CT23在女性恶性肿瘤(乳腺癌、卵巢癌、子宫内膜癌)诊断价值的探究<br>An Investigation of the Diagnostic Value of Cancer-Testis Antigen CT23 in Female Malignant Tumors (Breast, Ovarian, Endometrial)
%A 李安玲
%A 黄辉洋
%A 常升搏小吉
%A 庄棵捷
%A 陆春秀
%A 杨可
%A 韦星宇
%A 蓝利
%A 曾霞
%J Asian Case Reports in Emergency Medicine
%P 154-161
%@ 2328-0395
%D 2025
%I Hans Publishing
%R 10.12677/acrem.2025.132024
%X 目的&#65306;探讨CT23及其抗体在女性恶性肿瘤(乳腺癌、卵巢癌、子宫内膜癌)辅助诊断中的应用价值。方法&#65306;选取卵巢癌患者65例、乳腺癌患者54例、子宫内膜癌患者35例、盆腔良性肿瘤患者21例及健康对照组70例&#65292;通过ELISA检测血清中CT23含量及CT23抗体表达水平。结果&#65306;肿瘤组患者的CT23和CT23抗体平均含量均高于健康对照组&#65292;其中卵巢癌患者组与健康对照组差异具有统计学意义(P &lt; 0.001)。ROC曲线分析显示&#65292;CT23对女性肿瘤的诊断价值有限&#65292;而CT23抗体可能是乳腺癌或卵巢癌的中度血清标志物。结论&#65306;CT23抗体在乳腺癌和卵巢癌的诊断中具有一定的参考价值&#65292;但其临床意义仍需进一步研究验证。<br>Purpose: To explore the application value of CT23 and its antibody in the auxiliary diagnosis of female malignant tumors (breast, ovarian, endometrial). Methods: A total of 65 patients with ovarian cancer, 54 patients with breast cancer, 35 patients with endometrial cancer, 21 patients with benign pelvic tumors, and 70 healthy controls were selected. The levels of CT23 and CT23 antibody in serum were detected using ELISA. Results: The average levels of CT23 and CT23 antibody in the tumor group were higher than those in the healthy control group, with statistically significant differences in the ovarian cancer patient group (P &lt; 0.001). ROC curve analysis showed that CT23 had limited diagnostic value for female tumors, while CT23 antibody might be a moderate serum marker for breast cancer or ovarian cancer. Conclusion: CT23 antibody has certain reference value in the diagnosis of breast cancer and ovarian cancer, but its clinical significance requires further research and verification.
%K CT23&#65292
%K 癌&#8211
%K 睾丸抗原&#65292
%K 女性恶性肿瘤<br>CT23
%K Cancer-Testis Antigen
%K Female Malignant Tumors
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=112941